L'hôpital Cochin est un hôpital de l'Assistance publique - hôpitaux de Paris dans le 14ᵉ arrondissement de Paris. Il dépend de la faculté de médecine de l'Université de Paris. Il est situé 27 rue du Faubourg-Saint-Jacques.

During the past decade, Hôpital Cochin/Service d'Hématologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Cochin/Service d'Hématologie" #1 collaborator was "Aprea Therapeutics" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator, "Genzyme, a Sanofi Company" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Cochin/Service d'Hématologie" are "Myelodysplastic Syndrome" (3 trials), "Chronic Myelomonocytic Leukemia" (2 trials), "Acute Myeloid Leukemia" (1 trials), "Acute Myeloid Leukemia With Gene Mutations" (1 trials) and "Myelodysplastic Syndrome With Gene Mutation" (1 trials). Many other conditions were trialed in "Hôpital Cochin/Service d'Hématologie" in a lesser frequency.

Most popular intervention types in "Hôpital Cochin/Service d'Hématologie" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "APR-246" (1 trials), "Azacitidine" (1 trials), "Azacitidine and oral vorinostat" (1 trials), "Azacitidine combined to Lenalidomide" (1 trials) and "Clofarabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Cochin/Service d'Hématologie" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Cochin/Service d'Hématologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hôpital Cochin/Service d'Hématologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Cochin/Service d'Hématologie, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".